Your browser doesn't support javascript.
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease.
Pironi, Loris; Sasdelli, Anna Simona; Ravaioli, Federico; Baracco, Bianca; Battaiola, Claudia; Bocedi, Giulia; Brodosi, Lucia; Leoni, Laura; Mari, Giulia Aurora; Musio, Alessandra.
  • Pironi L; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Electronic address: loris.pironi@unibo.it.
  • Sasdelli AS; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Ravaioli F; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Baracco B; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Battaiola C; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Bocedi G; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Brodosi L; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Leoni L; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Mari GA; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Musio A; Clinical Nutrition and Metabolism Unit and Center for Chronic Intestinal Failure, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Clin Nutr ; 40(3): 1330-1337, 2021 03.
Article in English | MEDLINE | ID: covidwho-731735
ABSTRACT
RATIONALE The prevalence of malnutrition and the provided nutritional therapy were evaluated in all the patients with SARS-CoV-2 infection (COVID-19) hospitalized in a 3rd level hospital in Italy.

METHODS:

A one-day audit was carried out recording age, measured or estimated body weight (BW) and height, body mass index (BMI, kg/m2), 30-day weight loss (WL), comorbidities, serum albumin and C-reactive protein (CRP nv < 0.5 mg/dL), hospital diet (HD) intake, oral nutritional supplements (ONS), enteral (EN) and parenteral nutrition (PN). Modified NRS-2002 tool and GLIM criteria were used for nutritional risk screening and for the diagnosis of malnutrition, respectively.

RESULTS:

A total of 268 patients was evaluated; intermediate care units (IMCUs, 61%), sub-intensive care units (SICUs, 8%), intensive care units (ICUs, 17%) and rehabilitation units (RUs, 14%) BMI <18.5, 9% (higher in RUs, p = 0.008) and ≥30, 13% (higher in ICUs, p = 0.012); WL ≥ 5%, 52% (higher in ICUs and RUs, p = 0.001); CRP >0.5 78% (higher in ICUs and lower in RUs, p < 0.001); Nutritional risk and malnutrition were present in 77% (higher in ICUs and RUs, p < 0.001) and 50% (higher in ICUs, p = 0.0792) of the patients, respectively. HD intake ≤50%, 39% (higher in IMCUs and ICUs, p < 0.001); ONS, EN and PN were prescribed to 6%, 13% and 5%, respectively. Median energy and protein intake/kg BW were 25 kcal and 1.1 g (both lower in ICUs, p < 0.05) respectively.

CONCLUSIONS:

Most of the patients were at nutritional risk, and one-half of them was malnourished. The frequency of nutritional risk, malnutrition, disease/inflammation burden and decrease intake of HD differed among the intensity of care settings, where the patients were managed according to the severity of the disease. The patient energy and protein intake were at the lowest limit or below the recommended amounts, indicating the need for actions to improve the nutritional care practice.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Malnutrition / Nutrition Therapy / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Clin Nutr Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Malnutrition / Nutrition Therapy / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Clin Nutr Year: 2021 Document Type: Article